Bringing together people working at the cutting edge of small animal and equine osteoarthritis treatment with the companies driving technology, supplies and services, the Veterinary Osteoarthritis Congress is open to both VOA members and non-members, including veterinary surgeons, nurses, physiotherapists and others engaged in hydrotherapy and rehabilitation.
Day 1 has two small animal streams – session headings include ‘Managing OA’ and ‘Dealing with chronic pain’; and an equine stream looking at ‘Multidisciplinary management of OA’, ‘OA treatment options’ and ‘Unusual presentations’.
On day 2, ‘Biomodulation in OA’, ‘Working dogs’, ‘Mobility clinic’, and ‘Feline OA focus’ will run alongside sessions on ‘Rehab in action’, ‘Surgery in OA’ and ‘Dietary supplements’.
There’ll also be case presentations and interactive sessions on both days, with demonstrations and lectures from some of the leading firms.
Seven sessions in each stream offers two days of CPD.
After the first day’s sessions there’ll be a happy hour followed by a gala dinner in the Kings Hall. The event is being sponsored by Animalcare (Platinum), TVM UK and the Canine Hydrotherapy Association (Gold) with more to be announced soon.
Professor Stuart Carmichael, co-founder and director of the VOA, said: “Exciting developments are happening in veterinary OA, so we felt now is the right time to put this event on.
"There’s nothing specialist about osteoarthritis treatment and management: every small animal and equine practice deals with OA every day.
“There’s a real need and enthusiasm for bringing the latest thinking to as wide an audience as possible, so VOACON offers sessions for all members of the practice, whatever their interest is, along with rehab and physio teams.
"It’s actually been pretty difficult fitting everything in, but we’re confident we’ve got a great programme offering real, practical CPD that will benefit practices, their clients and their patients.”
Delegate rates for VOA members are:
Non-members (who can join the VOA when booking to qualify for members’ rates):
Rates include a hot buffet lunch, congress book and CPD certification.
To book or to download the programme, visit www.vet-oa.com/voacon.
Polypropylene or plastic-based wipes, which have been industry standard due to their reliable nature and compatibility with biocidal active materials, are due to be banned in the UK, because they take up to 100 years to break down.
Byotrol says its new wipes are made using a plastic-free 100% biodegradable substrate that deteriorates 3 months after disposal.
The company adds that the new wipes are proven to destroy bacteria, yeast, enveloped viruses, and fungi on non-porous surfaces and are effective against animal-specific pathogens such as: Brucella canis, Streptococcus equi, Staphylococcus aureus, Salmonella typhimurium, Bordetella bronchiseptica, Coronaviruses, Feline Immunodeficiency Virus (FIV), and Microsporum canis and Trichophyton mentagrophytes
Jane Kiely, Head of Marketing at Byotrol said: “Launching the Anigene Professional Surface Disinfectant Wipes is the final step in removing plastic wet wipes from our portfolio and a significant milestone in Byotrol’s sustainability journey.
"We are proud to be at the forefront of sustainability in the veterinary industry, offering an effective and regulatory-compliant product range that meets the needs of our customers”
Byotrol will be on Stand F18 at the London Vet Show.
https://byotrol.com
The company says its service has been designed to help practices take a proactive approach to managing their workforce, keeping them out of the employment tribunal and providing continued support to help them achieve their goals.
Melanie Davies, Head of Employment at MS Rubric (pictured right) said: "Whether a business employs 5 people or 500, is a start-up, or has been successfully trading for years, it is critical that it has a reliable legal advisory system in place to manage the range of challenges that arise.
"All businesses need to be able to access a professional source of advice and guidance to meet their objectives for best practice, compliance or to meet commercial goals and targets.
"With legislation changing so frequently, this legal expertise is sometimes missing from some businesses. As business owners realise its importance, they are relying more on external HR and legal experts like ourselves to provide this service. We think it’s so important, we are making this available to all sectors of business.”
MS Rubric adds that all its advice is covered by legal professional privilege. This means that unlike when businesses use HR or other consultancies, conversations between MS Rubric and its clients remain confidential and disclosure is not required.
For more information, contact Melanie Davies on 01454 800008 or mel.davies@msrubric.co.uk.
Horiba says subclinical hypocalcaemia (SCH) is a significant and under-diagnosed metabolic problem in dairy cattle affecting up to 50% cows annually.
After lactation, total calcium levels in the cows’ blood drop which can lead to sub-optimal health and yield.
The webinar will be presented by James Husband BA, VetMB, DipECBHM, DCHP, MRCVS, who will offer the benefit of his research and experience on the subject.
At the end, there'll be a Q&A session.
During the webinar, Horiba will also introduce its patient-sideLAQUAtwin Ca-11C pocket meter, which measures blood ionised calcium levels fast and is currently on special offer until 30th June 2022.
To register, visit: https://register.gotowebinar.com/register/6274625209458361872
Whilst you're there, the company will doubtless use the opportunity to bend your ear about how its technology can save time, drive revenue, and strengthen patient care.
Still, all in a good cause, and the company says it expects to be making a significant donation towards supporting members of the veterinary community who are experiencing financial and mental health challenges.
ezyVet Chief Growth Officer Pete Brown said: ““As innovators in the veterinary software space, we’re passionate about bettering the lives of veterinary professionals and we recognise the critical work Vetlife is doing to support the hard-working veterinary community.
"We’re going to be donating £1 to Vetlife for every person that visits the ezyVet booth at the London Vet Show, so we encourage everyone to come down and help us support this very worthwhile cause.”
Woodley Equipment has expanded its support team with the appointment of Greg Woloszczuk as the new Wet Chemistry Product Support Specialist.
Greg joins Woodley from the veterinary industry where he worked for 5 ½ years as a Service Manager. He will focus on all areas of customer service, pre and post sales, along with organising servicing, repairs and maintenance of the Woodley wet chemistry analysers.
On top of that, over 25% of vets said they don't talk to their farmer clients about the disposal of empty pharmaceutical waste.
The survey also found that while veterinary surgeons are aware that both glass and shatterproof plastic vials are incinerated, over 65% of those questioned believed that glass vials were more environmentally friendly, when in fact, the company says its CLAS (Ceva Layered Anti Shatter) shatterproof plastic vials have 33% less impact on the environment from cradle to grave2.
Ceva is producing a range of support materials, including tailored social media and newsletter content, to help vets to raise awareness of their pharmaceutical waste disposal service and drive improvements across the industry.
Peter Keyte, ruminant business unit manager at Ceva Animal Health said: "As an industry we should be doing all that we can to improve our environmentally friendly credentials.
“Ceva will continue to invest in innovative eco-friendly technology for livestock injectables and pioneer improvements to help ensure best practice throughout the industry.”
For further information, or to request a pharmaceutical waste disposal service support pack, contact your local Ceva account manager or call 01494 781510.
References
For the study1, which was conducted from March 2011 to August 2021, the cases of 50 puppies aged 3 to 6 months with unicondylar fractures were reviewed.
The sample included 30 fractures in 29 dogs treated with transcondylar bone screws and K-wires.
All fractures healed successfully.
The study included 24 male and 26 female puppies, with French Bulldogs representing 50% of the cases, ages ranging from 11 to 30 weeks and bodyweight varying from 1.5 to 16.9 kg, with a median of 5.5 kg.
Short-term outcomes were excellent in 77% of cases and good in 23%.
No catastrophic failures occurred, and the four complications encountered were resolved with further minor surgery.
The author says that while recent studies have raised concerns about the stability of using K-wires, rather than bone plates, this one suggests that for puppies at least, the combination of a transcondylar bone screw and K-wire is effective.
The incidence of implant-related complications was lower than in adult dogs, and the short-term outcomes were excellent or good in all cases with follow-up data.
The research underscores the need for further multicentre studies with longer-term follow-up to confirm these findings and compare them with other fixation techniques.
However, this study concludes that while epicondylar plates have become accepted practice for adult dogs with such fractures, they may not be necessary for puppies aged 3 to 7 months.
Study in full: https://cgrp01mstr8u1x2prod.dxcloud.episerver.net/globalassets/stock-images/humeral-condylar-paper---weighbridge-referral-centre---cvs.pdf
www.weighbridgevets.co.uk
Reference
The Small Animal Medicine Society (SAMSOC) and the BSAVA have together produced a new poster containing guidelines for the appropriate use of antibiotics in practice.
In recent years, alongside wider recognition of resistant bacteria such as MRSA in animals, the veterinary profession's use of antibiotics has been under the spotlight as a possible factor contributing to the increasing prevalence of bacterial resistance seen in human patients. Veterinary surgeons are faced with the dual problem of treating more and more resistant bacterial infections, whilst the threat of withdrawal of the right to prescribe certain antibiotics hangs over the profession.
SAMSoc and the BSAVA say they feel the time has come for the veterinary profession to take a coordinated responsible approach to its prescribing practices.
Ian Battersby of the Small Animal Medicine Society (SAMSoc) has sought to address the need for rational guidelines for the most appropriate antibiotics, for the correct duration, to maximise clinical efficacy but minimise selection of resistant bacteria. Collaboration with BSAVA resulted in a set of helpful prescribing guidelines in poster form, being sent to members of both associations. A limited number of copies will also be available from the BSAVA Balcony at Congress 2012, and BSAVA has dedicated the October issue of its membership magazine, companion, to the subject.
Ian said: "Of course these PROTECT guidelines are suggestions based on current knowledge and in the future we hope they will be further refined as our experience grows. This is an evolving situation and hopefully more work will be undertaken, in particular looking at treatment durations, allowing further refinement and optimization of practice policies. The key principles are that by implementing a prescribing protocol in our practices we are treating our prescribing privileges responsibly and maximizing the efficacy of the presently available agents for the benefit of both veterinary and human patients now and in the future.
"I would like to particularly thank everyone who has helped with this project; Andrew Jagoe, Professor Ian Ramsey, Tom Maddox, Jon Camillari, Alison Woodward and Dr Tim Nuttall, and BSAVA for facilitating the production of the poster".
The Veterinary Marketing Association has announced details of a new award for public relations, open to veterinary practices and companies.
The VMA says this award is to recognise the value that media and public relations can add to the marketing mix. It will be awarded to the company or veterinary practice that has delivered the most innovative PR campaign during 2011, as judged by a panel of industry professionals.
Organiser Claire Edmunds said: "The VMA Awards has become a coveted event for those involved in the animal health industry to showcase their marketing achievements. A range of categories has evolved since the awards began over 20 years ago, for marketing, creative communication and new media campaigns. However, we felt that an award for PR was required to complete the marketing mix".
Jane Manning from award sponsor Splash Marketing & Communications said: "We felt it was time to give the opportunity for those involved in PR to obtain the recognition they deserve alongside their creative colleagues.
"An effective PR campaign can be a highly influential marketing tool, so it's great news that the VMA has added this new award category. We hope that companies and agencies serving the animal health sector will embrace this new opportunity to showcase their creativity and hard work".
The award is for the most innovative PR initiative published during the year. This can be a single 'one-off' event or article, or a sustained campaign over a given period. The winner and two highly commended entries will be awarded at the VMA Awards on Friday 9th March 2012 at Shakespeare's UnderGlobe Theatre, London.
Further information on the awards and ticket application forms are available at the VMA's website - http://www.vma.org.uk/ or by calling 0844 561 6157. The deadline for entries is Friday 27th January 2012.
A new study published in Equine Veterinary Journal's (EVJ) in partnership with the American Association of Equine Practitioners, has shown that a wireless, inertial sensor-based system can effectively measure a horse's response to a flexion test.
The authors say that opinions on the value of flexion tests in assessing equine lameness have been divided for many years, but their research should turn what has always been regarded as a subjective process into a wholly objective one.
Flexion tests are used routinely in horses with subtle or imperceptible lameness, to exacerbate the problem and make it apparent to the observer. The test involves applying a short period of pressure to the joints of the limb before re-examination, and evaluating any change in gait. However, flexion tests rely on the ability of the observer to identify and interpret changes in the horse's gait and in that respect these tests are subjective and not necessarily consistent between observers.
The research study was conducted by orthopaedic surgeons based at the University of Glasgow's School of Veterinary Medicine1. A total of 17 healthy adult horses, all in work, were fitted with sensors before being trotted in a straight line. The sensors measured vertical pelvic movement asymmetry for both right and left hind limb strides and the average difference in maximum and minimum pelvic height between right and left hind limb strides. A hind limb was randomly selected for 60 seconds of proximal flexion, after which the horse was trotted for a minimum of 10 strides. Response to the flexion was blindly assessed as negative or positive by an experienced observer.
John Marshall, lecturer in equine surgery at the University of Glasgow, who led the study, said: "A positive response to flexion resulted in significant changes to objective measurements of pelvic symmetry, supporting the use of inertial sensor systems to objectively assess response to flexion tests."
Professor Jim Moore, North American Editor of the EVJ, said: "The introduction of an objective approach to documenting lameness examination will not only help vets and trainers to investigate equine lameness more accurately. It will also serve as an unbiased method of communicating lameness examination findings among vets, trainers, farriers and other professionals."
The next phase of research will be to establish cut-off values for objective assessment of other equine lameness diagnostic procedures, such as nerve blocks.
The survey is the second stage of a three stage review recommended to RCVS Council by the College’s Standards Committee in 2019, after it looked at the implications of new technologies for both animal welfare and veterinary regulation.
The main areas under consideration include the provision of 24/7 emergency cover and the interpretation and application of an animal being under the care of a veterinary surgeon. The review also encompasses remote consulting.
In stage one of the review, the RCVS commissioned a research agency to conduct a series of focus group discussions with veterinary professionals working in a variety of roles and sectors. The information gleaned from the discussions was then used to develop the questions for this survey.
The survey will ask veterinary professionals to reflect on what, for them, should underpin good regulations and guidelines for practice.
It will then ask respondents how these principles should be applied in particular situations relating to 24/7 emergency cover and 'under care' before inviting their views on how they would like regulations on these two areas to deal with any tensions between different desirable regulatory aims.
The survey results will be used to help produce any changes to the RCVS Code of Professional Conduct and its supporting guidance concerning ‘under care’ and the provision of 24/7 emergency cover, which will then be put out for full public consultation later this year.
Chair of the RCVS Standards Committee, Dr Melissa Donald, said: “This review addresses fundamental questions about how we should continue to interpret ‘under care’ in a profession, and a society, that is largely unrecognisable to the one that first defined the term, and, at the same time, how we can continue to provide 24/7 emergency cover for those animals under our care.
“The original Vet Futures report also emphasised the impact that technological advances may have on the veterinary professions, so we must ensure we have in place a regulatory framework that gives consideration to these potential changes whilst ensuring animal health and welfare remain at its heart.
“These are challenging but hugely important questions on which we are hoping to receive as much feedback as possible. I do understand the huge pressures my vet and vet nurse colleagues continue to work under at the moment, so would like to thank them in advance for taking a little time out of their busy days to send us their views.”
The survey will open on Wednesday, 19th May 2021 for all UK-based veterinary surgeons and veterinary nurses.
All responses will be used and reported anonymously, so respondents will not be identified.
The survey will be open for four weeks, closing at 5pm on Wednesday, 16 June 2021.
It should take 15-20 minutes to complete, but can be returned to and completed in stages if preferred.
Further background information about the Under Care Review is available at www.rcvs.org.uk/undercare.
AmpliSpec LAB Mastitis uses isothermal amplification technology, which means laboratories can use less expensive equipment.
It also uses the company's lyophilised bead platform, designed to make the test stable and easy to use.
Biotangents says its new test will offer notable cost, speed and accuracy benefits over the traditional culture and PCR testing used by animal health laboratories and veterinary clinics around the world.
CEO Fiona Marshall said: “With 93% sensitivity and 95% specificity, this is a highly sophisticated assay that will help farmers, vets and laboratories to better treat mastitis.
http://www.biotangents.co.uk
The RCVS Disciplinary Committee has suspended a Co. Tyrone veterinary surgeon from the Register for ten months, having found him guilty of serious professional misconduct relating to three convictions for contravening animal export regulations.
Whilst working as an Authorised Veterinary Inspector in Castlederg for the Department of Agriculture and Rural Development (DARD), William Manson had falsely certified that he had inspected three consignments of sheep presented for assembly at Plumbridge Export Assembly Centre on 16 and 23 August 2009. At this week's two-day hearing, Mr Manson admitted that the convictions he had received at the Strabane Magistrates Court on 26 November 2010 made him unfit to practise veterinary surgery, but said in mitigation that he had examined the sheep nearby at Landahussy, a site he considered more suitable for a large number of animals.
The Committee was satisfied that Mr Manson believed the Landahussy site to be more suitable for large deliveries; the Committee also was satisfied that he did carry out a visual inspection of the sheep at the Landahussy site on 16 and 23 August 2009. However, the information Mr Manson provided on the three certificates was false and misleading. Mr Manson had also been reminded of the importance of complying with government regulations in a disciplinary case in 2004, following convictions for failing to notify DARD about changes in the number of sheep for which he was claiming a premium. The then Committee dismissed the case, deeming the convictions a result of his "genuine but regrettable oversight".
Speaking on behalf of the Committee, Chairman, Prof Peter Lees said: "Mr Manson's actions in certifying that he had examined the sheep at an approved assembly centre when he had not done so amounted to a serious departure from professional standards. If there had been a disease outbreak on either the Plumbridge or Landahussy site, such actions would have rendered contact tracings unreliable and inaccurate."
In mitigation, the Committee accepted medical evidence and Mr Manson's testimony that he was at that time under exceptional stress. He was working long hours in difficult circumstances without an assistant, and was under considerable personal pressure as a result of his wife's serious illness. It also took into account his age (66), exceptional testimonials produced on his behalf, and the impact on the community he served.
Prof Lees said: "The Committee has concluded that the removal of Mr Manson's name from the Register is neither proportionate nor necessary in the public interest nor to protect the welfare of animals. A proportionate sanction in this case is to suspend Mr Manson's name from the Register for a period of ten months."
Anne is originally from New York City and obtained her veterinary degree from Purdue University in 2011.
She completed her rotating internship at Louisiana State University, followed by two research fellowships at Michigan State University and Nihon University.
She then completed her residency at the RVC, before achieving diplomate status of the American College of Veterinary Internal Medicine (Cardiology) in 2017.
Anne's interests include treatment and management of congestive heart failure, feline cardiomyopathy and cardiac interventions.
She said: “I’m delighted to be joining the cardiology team at DWR at a very exciting time, supporting the recently-launched open-heart surgery service.
“We’re one of very few hospitals in the world to be able to offer this treatment, so being a part of this is a great challenge, both personally and professionally.”
For more information visit www.dickwhitereferrals.com
In his new role, Ian will guide the development of interventions, strategies, process changes and campaigns to improve responsible pharmaceutical usage across Mars Veterinary Health’s 2,500+ global veterinary clinics.
Ian was previously Head of Internal Medicine at Hertfordshire-based Davies Veterinary Specialists and antimicrobial resistance (AMR) subject matter expert on the clinical board of Linnaeus.
Mars says that this new role is one of several actions it is taking to promote pharmaceutical stewardship and combat antimicrobial resistance, include the implementation of a formal responsible pharmaceutical stewardship programme across all its veterinary clinics globally during the next several years.
Ian said: “As one of the leading providers of veterinary care in the world, we have a unique opportunity – and responsibility – to lead the way toward a more sustainable profession.
“Antimicrobial resistance is a critical One Health issue, and I look forward to continue working with colleagues across more than 2,500 clinics to support responsible antibiotic prescribing.
"Energy and interest in this area is growing profession-wide, demonstrating a reassuring recognition of how we can make meaningful improvements for people, pets, and the planet long into the future.”
Clare (pictured) who is currently the General Dental Council’s Interim Executive Director for Legal and Governance, will be joining the RCVS as its most senior legal officer at the end of March 2025.
A qualified solicitor, Clare started her practice as a Solicitor Advocate in criminal law, before undertaking roles in regulatory bodies in the healthcare and financial sector.
She joined the General Dental Council in March 2023 and has been in her current role there since March last year.
When she joins the College, Clare will have a dual role.
As Registrar she will be responsible for keeping, maintaining and publishing Registers of veterinary surgeons and veterinary nurses, including oversight of the various mechanisms via which veterinary professionals can join the Register, what they need to do to stay on the Registers, how they may leave or be removed and registration appeals.
As Director of Legal Services, she'll provide leadership and guidance on legal matters within the organisation, including guiding RCVS Council through the development of oral and written legal advice, as well as sitting on committees and working groups in order to ensure the College’s activity is within its legal remit and represents best practice.
RCVS Chief Executive Officer Lizzie Lockett said: “I am sure the RCVS, the professions and the public will benefit from her very relevant experience from senior roles within the General Dental Council, Nursing and Midwifery Council, and Financial Conduct Authority, as well as her private sector legal experience.
“She joins the College at a time of change, with our continued push for new veterinary legislation, the ongoing Competition and Markets Authority investigation of the sector, and a new strategic plan for the College due to be approved this spring.
“The Registrar is the senior legal figure within the organisation, and I am looking forward to Clare contributing her legal expertise on these significant areas of work.
"She joins our very capable legal team, who I am sure will benefit from her leadership, as she will benefit from their sector expertise.”
Clare said: “I am delighted to join the Royal College of Veterinary Surgeons to contribute to the valuable work of safeguarding the interests of the public and animals by supporting veterinary professionals to provide the highest standards of care.”
VetSurgeon.org extends a warm welcome to Clare and wishes her all the very best in her new position.
One small but nevertheless important point is that perhaps a better aim would be to support veterinary professionals in providing just a 'high' standard of care, rather than the 'highest' standards.
It's this constant striving for the 'highest' standards from both a regulatory and clinical perspective that is driving up the cost of veterinary care and making it unaffordable.
VetCell Bioscience has become the first UK-based stem cell centre to be authorised under the Veterinary Medicines Regulations.
Following a rigorous series of inspections and reports by Good Manufacturing Practice (GMP) Inspectors VetCell, in conjunction with their UK laboratory partner Biobest, were officially authorised as an equine stem cell centre on 1 October 2009.
David Mountford, Chief Operating Officer of VetCell Bioscience said: "To have received formal authorisation so swiftly reflects the high standard of our operation and our ability to lead the field in the increasingly competitive sector of stem cell technology."
Stem cell therapy involves implanting millions of the animal's own stem cells and autologous growth factors directly into the injured tendon or ligament. The service VetCell Bioscience offers is the collection, storage, processing and supply of stem cells suitable for administration back into the donor animal.
According to the company, there is considerable interest from the human sector and studies in human medicine, for the treatment of Achilles tendinopathies, could begin as early as next year.
The Council of the Royal College of Veterinary Surgeons has approved a new Health Protocol, which formalises a more compassionate approach to veterinary surgeons with health problems.
The Protocol will allow - in appropriate circumstances - veterinary surgeons (and, from next year, registered veterinary nurses) who suffer from health concerns affecting their ability to practise safely, to have the matter dealt with confidentially, without going to a full public Disciplinary Committee hearing.
It will allow individuals to access appropriate support and help away from the public spotlight, while ensuring that they do not put animals or the public at risk.
According to independent legal advice sought by the College, such an approach is appropriate and necessary in order for the College to fulfil its regulatory responsibilities - similar systems exist within other regulators.
The draft Protocol was the subject of consultation amongst the profession and the public over summer. Proposed amendments to the RCVS Guide to Professional Conduct, to support the introduction of the Health Protocol, were also approved in the November meeting.
RCVS Head of Professional Conduct, Gordon Hockey said: "The Protocol encourages anyone coming into contact with veterinary surgeons - including other veterinary surgeons, veterinary nurses, members of practice staff, clients and healthcare professionals - who have concerns about a veterinary surgeon's health to report those concerns to the RCVS as soon as is reasonably practicable.
"Veterinary surgeons and veterinary nurses who are concerned about the health of a veterinary surgeon must also take steps to ensure that animals are not put at risk and that the interests of the public, including those of their colleagues, are protected."
Culture Change In Healthcare is presented by Simon Fleming, a trauma and orthopaedic registrar who has a special interest in combating bullying, undermining and harassment in human healthcare, and Sally Everitt MRCVS, the ex Head of Scientific Policy at BSAVA.
Simon will discuss the problem of bullying, the fallout from serious cases, and how you can work to eliminate bullying in your practice.
Sally will present the results of a survey carried out by VetSurgeon.org and VetNurse.co.uk in 2017, to investigate the incidence and impact of unpleasant behaviour in veterinary practice.
The webinar is hosted by The Webinar Vet and sponsored by RCVS Mind Matters. It counts as 1hr towards your annual CPD requirement.
Whether or not you think there is any bullying going on at your practice, I strongly urge you to watch this webinar. There can be few things as harmful to an effective practice team as bullying. Everyone needs to be able to spot it and stamp on it quickly.
Register for the webinar here: https://www.thewebinarvet.com/pages/culture-change-healthcare-2/
Judges for the UK Rabbit Vet of the Year, the Rabbit Nurse of the Year and the Rabbit Veterinary Practice of the Year awards will be looking for exceptional knowledge of rabbit care and husbandry, and evidence of the winners’ continued commitment to educating the public on how to care for rabbits correctly.
Dr Suzanne Moyes MVB MRCVS, awards judge and Veterinary Director at Burgess Pet Care said: "These awards are our way of saying ‘Thank You’ to the veterinary professionals that are helping to improve the lives of pet rabbits."
Rae Todd, Director of the Rabbit Welfare Association & Fund said: "Rabbits make absolutely fantastic pets but research continues to show that there are still too many rabbit owners failing to meet the correct needs of their rabbits. We’re incredibly grateful for the growing number of vets that are working hard to address this, whether that’s by utilising the available rabbit CPD, taking part in events like Rabbit Awareness Week or generally making their practices more suitable environments for rabbit-owning clients."
Veterinary surgeons and nurses can self-nominate for these awards, and nominations are also being sought from the public.
The winners will each receive a cash prize of £500.
To enter the awards, visit www.burgesspetcare.com/excel-vet-awards.
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Maggie Fisher MRCVS, the parasitologist and chairman of ESCCAP (European Scientific Counsel Companion Animal Parasites), has highlighted studies which demonstrate an association between the common parasite, Toxocara spp. and human disease, and has called on the profession to help reduce the damaging and widespread effects of this parasite.
Maggie says that many in the profession may not be aware that Toxocara eggs aren't actually infective when they are first passed in an animal's stools, sometimes taking weeks to develop to this stage. Eggs persist long after pet waste has naturally washed away too, so the risk of infection still exists even in environments that appear to be clean and safe. Interestingly, there seems to be only a very loose (and according to some studies, entirely absent) link between owning a pet and an increased risk of human Toxocara infection, suggesting that most infections are acquired from the environment1,2 . Education of pet owners about responsible pet ownership, including appropriate worming and picking up their dog's waste quickly is essential to reduce this environmental infection risk.
The parasite's larval stages cause disease in humans as they migrate through body tissues, with retinal damage a previously well identified consequence. However, Maggie has identified studies which suggest a whole range of common conditions that may also be attributable to Toxocara infection. One study3 included 425 children displaying signs of a persistent cough and 1600 asymptomatic children as controls. Blood tests confirmed that a statistically significant 32% of the symptomatic group were positive for Toxocara antibodies, compared to just 17% of the asymptomatic control group. What's more, when given a week's course of an appropriate anthelmintic, the vast majority of symptomatic children had a greatly reduced and frequently absent requirement for inhaled corticosteroids to control their symptoms when re-examined by the study team a year later.
Numerous other studies from around the world have shown similar strong associations with asthma, allergies and epilepsy. One nationally representative US study even showed an alarming association with Toxocara infection and reduced cognitive function in children2 . Those that were positive for antibodies to the parasite on blood tests (proving prior exposure) scored significantly lower on tests assessing verbal and manual dexterity as well as maths and reading abilities2 .
So, what should veterinary staff and SQPs be telling clients? Maggie says you should be advising pet owners to worm pets regularly (at least four times a year) with an effective anthelmintic from an appropriately young age (2 weeks of age for puppies and 3 weeks of age for kittens, because transfer of the parasite to puppies before birth and to kittens via milk is a feature of the parasite lifecycle). Reducing pets' access to raw food and hunting activities can also help. This is in addition to more general recommendations including cooking food well and making sure children wash their hands before eating.
Maggie said: "Vets, nurses and SQPs are perfectly placed to make sure that pet owners are aware of the risks and take precautions to protect themselves and the wider general public."
For further information about effective control of Toxocara and a wide range of other companion animal parasites, visit www.esccapuk.org.uk. To view all the presentations from the 'Everyday Parasites' CPD day, visit www.esccapuk-cpd.co.uk.
References:
Zoetis (maker of Cerenia, the anti-emetic) is using social media for its latest campaign to remind owners that vets have a solution for dogs that suffer from travel sickness.
The company highlights research which shows the problem is more common than one might think, with 62% of dogs experiencing travel sickness for the first time as puppies. What's more, 1/3rd of owners say they would travel with their dogs more often if they didn't get car sick.
Stephanie Smith, Marketing Manager for Cerenia said: "While less than half of vets in the UK report seeing at least one canine motion sickness case each month, we know that over one third (34%) of dogs that travel experience motion sickness. That's a lot of opportunity for vets to provide pets and owners with some relief."
To spread the word, the company has set up an educational microsite: www.nonstoptravelfun.co.uk which it is now promoting with an online social media campaign, including twitter #nonstoptravelfun and targeted bloggers and pet sites. The company has also been advertising the microsite on Facebook and Google, which I'm told has driven thousands of visitors over the past fortnight.
Stephanie added: "Motion sickness can impact the whole family, making travelling an unpleasant experience. Our new campaign aims to raise awareness for the issue and encourage pet owners to seek veterinary help for the problem, so they can enjoy non-stop travel fun, without the sickness."